338 related articles for article (PubMed ID: 24596973)
1. [The concept of continuous dopaminergic stimulation in the treatment of late stages of Parkinson's disease].
Titova NV; Katunina EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):105-12. PubMed ID: 24596973
[No Abstract] [Full Text] [Related]
2. [Current possibilities of quality of life improvement in the late stages of Parkinson's disease].
Titova NV; Katunina EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3):94-100. PubMed ID: 26171484
[TBL] [Abstract][Full Text] [Related]
3. [Continuous dopaminergic stimulation in Parkinson disease].
Obeso JA; Luquin MR; Vaamonde J; Grandas F; Pastor MA; Artieda J; Martínez-Lage JM
Neurologia; 1987; 2(5):227-34. PubMed ID: 2908545
[No Abstract] [Full Text] [Related]
4. [Treatment possibilities in advanced Parkinson's disease].
Takáts A; Nagy H; Radics P; Tóth A; Tamás G
Ideggyogy Sz; 2013 Nov; 66(11-12):365-71. PubMed ID: 24555235
[TBL] [Abstract][Full Text] [Related]
5. New dopaminergic therapies for PD motor complications.
Larson D; Simuni T
Neuropharmacology; 2022 Feb; 204():108869. PubMed ID: 34742740
[TBL] [Abstract][Full Text] [Related]
6. [Optimization of the treatment of Parkinson's disease using dopamine agonists].
Rinne UK
Arch Neurobiol (Madr); 1991; 54(6):282-7. PubMed ID: 1687430
[No Abstract] [Full Text] [Related]
7. [Treatment of Parkinson disease in patients with surgical problems].
Sobolewski P
Neurol Neurochir Pol; 2003; 37 Suppl 5():183-8. PubMed ID: 15098345
[TBL] [Abstract][Full Text] [Related]
8. [Duodenale levodopa and apomorphine infusion for motor complications in advanced Parkinson's disease].
Antonini A; Jost WH
Fortschr Neurol Psychiatr; 2018 Sep; 86(S 01):S5-S9. PubMed ID: 30107620
[TBL] [Abstract][Full Text] [Related]
9. Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon.
Colosimo C; Merello M; Hughes AJ; Sieradzan K; Lees AJ
J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):634-7. PubMed ID: 8648329
[TBL] [Abstract][Full Text] [Related]
10. Continuous dopaminergic stimulation in Parkinson's disease.
Obeso JA; Luquin MR; Vaamonde J; Grandas F; Martinez Lage JM
Can J Neurol Sci; 1987 Aug; 14(3 Suppl):488-92. PubMed ID: 3676922
[TBL] [Abstract][Full Text] [Related]
11. [Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study].
Fedorova NV
Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):21-4. PubMed ID: 14681961
[TBL] [Abstract][Full Text] [Related]
12. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
Nutt JG
Neurology; 2006 May; 66(10):1611-2; author reply 1611-2. PubMed ID: 16717244
[No Abstract] [Full Text] [Related]
13. [Subcutaneous continuous apomorphine infusion: treatment initiation and follow up].
Grandas FJ; Sesar-Ignacio Á
Rev Neurol; 2012; 55 Suppl 1():S21-4. PubMed ID: 23169229
[TBL] [Abstract][Full Text] [Related]
14. Continuous levodopa infusion is better—for now.
Nutt JG
Mov Disord; 2015 Apr; 30(4):443-5. PubMed ID: 25757898
[No Abstract] [Full Text] [Related]
15. Apomorphine infusion and the long-duration response to levodopa in advanced Parkinson's disease.
Stocchi F; Berardelli A; Vacca L; Barbato L; Monge A; Nordera G; Ruggieri S
Clin Neuropharmacol; 2003; 26(3):151-5. PubMed ID: 12782918
[TBL] [Abstract][Full Text] [Related]
16. Oral formulations of L-dopa and continuous dopaminergic stimulation.
Iansek R; Danoudis M
Mov Disord; 2012 Apr; 27(4):579. PubMed ID: 22344707
[No Abstract] [Full Text] [Related]
17. Use of apomorphine in Parkinson's disease.
Stocchi F
Neurol Sci; 2008 Dec; 29 Suppl 5():S383-6. PubMed ID: 19381769
[TBL] [Abstract][Full Text] [Related]
18. The first miracle in neurodegenerative disease: the discovery of oral levodopa.
Kordower JH; Goetz CG
Brain Res Bull; 1999; 50(5-6):377-8. PubMed ID: 10643443
[No Abstract] [Full Text] [Related]
19. [Continuous dopaminergic stimulation in Parkinson disease: possibilities in 2013].
Aschermann Z; Kovács N; Komoly S
Ideggyogy Sz; 2013 May; 66(5-6):209-10. PubMed ID: 23909024
[No Abstract] [Full Text] [Related]
20. [Current treatment strategies for Parkinson's disease].
Südmeyer M; Wojtecki L; Schnitzler A
Fortschr Neurol Psychiatr; 2011 Dec; 79(12):733-43. PubMed ID: 22161168
[No Abstract] [Full Text] [Related]
[Next] [New Search]
